Por Renan Filho · 2026-10-11**Lead**
CDC Director Mandy Cohen today addressed growing concerns over reports of a possible plague-related biological threat emanating from Russia, stating that the United States is well-prepared and “protected” against any such event. During a press conference at the agency’s Atlanta headquarters, Cohen detailed the multi-layered federal response, which includes enhanced surveillance, stockpiled medical countermeasures, and interagency coordination. The briefing comes after intelligence assessments and media reports raised alarms about Russia’s potential development or deployment of plague-causing bacteria as a weapon.
**Context**
The concerns trace back to recent intelligence briefings that suggested Russian state actors may have been experimenting with *Yersinia pestis*, the bacterium responsible for plague, in violation of international treaties. Although no specific imminent attack has been confirmed, the US Department of Homeland Security and the Department of Defense have been monitoring the situation closely. Plague, which can manifest as bubonic, septicemic, or pneumonic forms, is highly contagious in its pneumonic form and has historically caused devastating pandemics. The US government has long maintained a biodefense infrastructure, including the Strategic National Stockpile, which contains antibiotics and vaccines effective against plague. The CDC’s Division of Select Agents and Toxins regulates possession of such pathogens, and the agency operates a network of laboratories capable of rapid diagnosis.
Cohen emphasized that the US has “layered defenses” that include early warning systems, real-time disease surveillance through the National Notifiable Diseases Surveillance System, and partnerships with state and local health departments. She noted that the CDC has conducted tabletop exercises simulating a plague outbreak and that response protocols are regularly updated. The director also highlighted ongoing collaboration with international partners, including the World Health Organization, to share intelligence and coordinate containment strategies.
**Analysis**
The director’s remarks underscore a broader shift in US biosecurity posture following the COVID-19 pandemic. The federal government has invested heavily in pandemic preparedness, including the creation of the Office of Pandemic Preparedness and Response Policy and increased funding for the Biomedical Advanced Research and Development Authority. These investments have strengthened the country’s ability to respond to both natural and deliberate biological threats. Cohen’s assurance that the US is “protected” reflects confidence in these systems, but experts caution that no defense is absolute. The pneumonic form of plague can spread through respiratory droplets, making early detection and rapid containment critical.
Moreover, the Russian plague concerns highlight the ongoing challenge of verifying compliance with the Biological Weapons Convention, which both the US and Russia have signed. Recent diplomatic tensions have eroded trust, and intelligence gaps remain. The CDC’s role extends beyond domestic preparedness to include global health security capacity building, which helps reduce the risk of outbreaks abroad that could reach US shores. Cohen’s briefing serves as a reminder that biological threats—whether state-sponsored or accidental—require constant vigilance and investment.
**Fontes**
- Centers for Disease Control and Prevention (CDC) press briefing, October 11, 2026 - US Department of Homeland Security, Intelligence and Analysis division - World Health Organization, Global Health Security Agenda - The Biological Weapons Convention, United Nations Office for Disarmament Affairs - Congressional testimony on biodefense, House Committee on Homeland Security (2025)